Bases de datos bibliográficos Pascal y Francis

Ayuda

Resultados de su búsqueda

Su búsqueda

au.\*:("BESAG, Frank M. C")

Año de publicación [py]

A-Z Z-A Frecuencia ↓ Frecuencia ↑
Exportación CSV

Disciplina (documento) [di]

A-Z Z-A Frecuencia ↓ Frecuencia ↑
Exportación CSV

País del autor

A-Z Z-A Frecuencia ↓ Frecuencia ↑
Exportación CSV

Resultados 1 a 19 de 19

  • Página / 1
Exportación

Selección :

  • y

Tonic seizures are a particular risk factor for drowning in people with epilepsyBESAG, Frank M. C.BMJ. British medical journal (International ed.). 2001, Vol 322, Num 7292, pp 975-976, issn 0959-8146Article

ADHD Treatment and PregnancyBESAG, Frank M. C.Drug safety. 2014, Vol 37, Num 6, pp 397-408, issn 0114-5916, 12 p.Article

Behavioural effects of the New AnticonvulsantsBESAG, Frank M. C.Drug safety. 2001, Vol 24, Num 7, pp 513-536, issn 0114-5916Article

Is generic prescribing acceptable in epilepsy?BESAG, Frank M. C.Drug safety. 2000, Vol 23, Num 3, pp 173-182, issn 0114-5916Article

Does Melatonin Affect Epileptic Seizures?JAIN, Siddharth; BESAG, Frank M. C.Drug safety. 2013, Vol 36, Num 4, pp 207-215, issn 0114-5916, 9 p.Article

Cardiovascular Effects of Methylphenidate, Amphetamines and Atomoxetine in the Treatment of Attention-Deficit Hyperactivity Disorder: An UpdateAWUDU, Gariba A. H; BESAG, Frank M. C.Drug safety. 2014, Vol 37, Num 9, pp 661-676, issn 0114-5916, 16 p.Article

Interactions between antiepileptic and antipsychotic drugsBESAG, Frank M. C; BERRY, David.Drug safety. 2006, Vol 29, Num 2, pp 95-118, issn 0114-5916, 24 p.Article

Cardiovascular Effects of Methylphenidate, Amphetamines and Atomoxetine in the Treatment of Attention-Deficit Hyperactivity DisorderSTIEFEL, Gary; BESAG, Frank M. C.Drug safety. 2010, Vol 33, Num 10, pp 821-842, issn 0114-5916, 22 p.Article

Methsuximide reduces valproic acid serum levelsBESAG, Frank M. C; BERRY, David J; VASEY, Michael et al.Therapeutic drug monitoring. 2001, Vol 23, Num 6, pp 694-697, issn 0163-4356Article

Prioritizing children's medicines for research : a pharmacoepidemiological study of antiepileptic drugsACKERS, Ruth; MURRAY, Macey L; BESAG, Frank M. C et al.British journal of clinical pharmacology. 2007, Vol 63, Num 6, pp 689-697, issn 0306-5251, 9 p.Article

Use of selective serotonin reuptake inhibitors in children and adolescentsWONG, Ian C. K; BESAG, Frank M. C; SANTOSH, Paramala J et al.Drug safety. 2004, Vol 27, Num 13, pp 991-1000, issn 0114-5916, 10 p.Article

Beneficial and Adverse Psychotropic Effects of Antiepileptic Drugs in Patients with Epilepsy: A Summary of Prevalence, Underlying Mechanisms and Data LimitationsPIEDAD, John; RICKARDS, Hugh; BESAG, Frank M. C et al.CNS drugs. 2012, Vol 26, Num 4, pp 319-335, issn 1172-7047, 17 p.Article

Lack of an effect of topiramate on lamotrigine serum concentrationsBERRY, David J; BESAG, Frank M. C; POOL, Felicity et al.Epilepsia (Copenhagen). 2002, Vol 43, Num 8, pp 818-823, issn 0013-9580Article

When is it inappropriate to prescribe psychotropic medication?BESAG, Frank M. C.Epilepsia (Copenhagen). 2002, Vol 43, pp 45-50, issn 0013-9580, SUP2Article

Safety, tolerability, and pharmacokinetics of remacemide in childrenBESAG, Frank M. C; NEWTON, Rosemary E; BLAKEY, Graham E et al.Pediatric neurology. 2001, Vol 24, Num 5, pp 352-356, issn 0887-8994Article

Treatment of state-dependent learning disabilityBESAG, Frank M. C.Epilepsia (Copenhagen). 2001, Vol 42, Num 1, pp 52-54, issn 0013-9580, SUPConference Paper

Trials in children. DiscussionsAMANN, J. P; DULAC, O; BESAG, Frank M. C et al.Epilepsy research. 2001, Vol 45, Num 1-3, pp 133-140, issn 0920-1211Conference Paper

Cognitive and behavioral outcomes of epileptic syndromes : Implications for education and clinical practiceBESAG, Frank M. C.Epilepsia (Copenhagen). 2006, Vol 47, pp 119-125, issn 0013-9580, 7 p., SUP2Article

Mortality Rates and Causes of Death in Children with Epilepsy Prescribed Antiepileptic Drugs: A Retrospective Cohort Study using the UK General Practice Research DatabaseACKERS, Ruth; BESAG, Frank M. C; HUGHES, Elaine et al.Drug safety. 2011, Vol 34, Num 5, pp 403-413, issn 0114-5916, 11 p.Article

  • Página / 1